The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Study Type
OBSERVATIONAL
Enrollment
100
Device that measures how much blood is being pumped in and out of the heart.
Mount Sinai Hospital
New York, New York, United States
RECRUITINGSystemic vascular resistance obtained from USCOM
Cardiac output related to systemic vascular resistance (SVR) obtained from the USCOM device. SVR is an indicator of general resistance experienced within the circulatory system and is correlated with an array of cardiac related adverse health outcomes. The USCOM device uses noninvasive ultrasonographic technology to determine SVR at the time of prenatal ultrasound.
Time frame: every 2-4 weeks at time of prenatal ultrasound, until the end of pregnancy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.